Avicanna Inc's stock is facing a notable decline in today's trading session.
Avicanna Inc (AVCN.TO) is experiencing a downturn, with shares sliding by 4.55% to a real-time close of CA$0.10. This decline raises questions about the company's current market position and investor sentiment.
Investor takeaway: Investors should be cautious as Avicanna's stock struggles to maintain momentum amidst a challenging market environment.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.78M
52W high
$0.30
52W low
$0.10
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 536.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+536.4% Upside
Current Price
C$0.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
95.6%
Annualized
90-Day Vol
81.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.14 |
| 60 trading days | C$0.10 | C$0.06 – C$0.16 |
| 90 trading days | C$0.09 | C$0.05 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avicanna Inc's stock drops 4.55% today
Advertisement
With a market cap of CA$14.78 million, Avicanna's stock performance is under scrutiny as it continues to face challenges in a competitive sector.
Bull case
Despite today’s decline, Avicanna is actively expanding its healthcare initiatives. The recent launch of the MyMedi.ca Integrated Healthcare Program could help the company reach more customers and improve its standing in the market.
Bear case
Today's stock performance reflects ongoing investor concerns, especially with Avicanna's negative profit margin of -14.75%. This figure raises flags about the company’s financial stability and its ability to recover in a tough market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
